When mortality from melioidosis fell sharply after multiple changes in management at an Australian hospital, doctors wanted to identify whether a new drug was responsible. But designing a trial that was ethically acceptable proved impossible
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC286254 | PMC |
| http://dx.doi.org/10.1136/bmj.327.7426.1280 | DOI Listing |
Publication Analysis
Top Keywords
ethical problems
4
problems evaluating
4
evaluating treatment
4
treatment melioidosis
4
melioidosis mortality
4
mortality melioidosis
4
melioidosis fell
4
fell sharply
4
sharply multiple
4
multiple changes
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!